We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
38 hedge funds and large institutions have $39.8M invested in scPharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.69% less ownership
Funds ownership: 58.03% → 57.34% (-0.69%)
56% less capital invested
Capital invested by funds: $90.1M → $39.8M (-$50.3M)
Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
16
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$13.4M |
| 2 |
Belvedere Trading
Chicago,
Illinois
|
+$388K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$182K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$158K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$77.9K |
